Epithelial cell membranes and oropharyngeal mucosal surfaces

The epithelial cell membranes and oropharyngeal mucosal surfaces represent the anatomical and cellular boundaries of the upper aerodigestive tract, serving as a critical interface for host-environment interactions. These surfaces are primarily composed of stratified squamous epithelium, which provides a physical and chemical barrier through tight junctions and the secretion of a protective mucus layer containing antimicrobial proteins and secretory IgA (StatPearls, 2023). While not a single molecular target, these membranes are the site of action for various topical therapeutics, including local anesthetics like lidocaine that stabilize neuronal membranes and antiseptics like chlorhexidine that disrupt microbial cell membranes (PubMed, 2019). Pathologically, the oropharyngeal mucosa is a major site for the entry of respiratory viruses, such as SARS-CoV-2, which utilizes membrane-bound receptors like ACE2 for cellular invasion (Nature Medicine, 2021). Additionally, these surfaces are susceptible to treatment-induced damage, such as oral mucositis in oncology patients, which involves complex inflammatory cascades and loss of epithelial integrity (NIH, 2022). Therapeutic strategies targeting these surfaces often focus on enhancing barrier function, providing localized pain relief, or preventing pathogen colonization through topical delivery systems.

Other names

Oropharyngeal mucosaOral epitheliumPharyngeal mucosal liningOropharyngeal surface

Drugs interacting with these surfaces typically act via topical application to provide local anesthesia by stabilizing neuronal membranes, antimicrobial activity by disrupting microbial cell walls, or physical protection of the mucosal barrier.